Clinical Trial

Effect of Mutations in T2DM Susceptibility Genes on the Expression of Susceptibility Genes in Patients With T2DM and Controls

Recruiting
View on ClinicalTrials.gov →
Summary
In this study, investigators wanted to determine the effect of T2DM susceptibility gene mutations on self-expression. Participants (T2DM patients and controls) were recruited to identify genotypes and detect the levels of T2DM susceptibility genes expression in the fresh peripheral plasma. The normal pancreatic tissues or adjacent tissues of pancreatic cancer were also collected to identify the expression differences of T2DM susceptibility genes under different genotypes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-02-18.
Trial Details
NCT Number NCT06277466
Lead Sponsor The Affiliated Hospital of Xuzhou Medical University
Conditions Type 2 Diabetes Mellitus, Gene Polymorphisms, Genetic Mutations, Susceptibility, Genetic
Enrollment 300 participants
Start Date 2024-01-01
Primary Completion 2028-01-31 (estimated)
Study Completion 2028-01-31 (estimated)
Updated on ClinicalTrials.gov 2024-02-28